Phase 2 Trial of Dose Dense (Weekly) Paclitaxel with Pembrolizumab (MK-3475) in Platinum Resistant Recurrent Ovarian Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
H. Lee Moffitt Cancer Center & Research Institute
Start Date
August 12, 2016
End Date
December 18, 2019
Administered By
Duke Cancer Institute
Awarded By
H. Lee Moffitt Cancer Center & Research Institute
Start Date
August 12, 2016
End Date
December 18, 2019